Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07195604
PHASE1
A Single Ascending Dose of HRS-2162 in Healthy Subjects
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
View on ClinicalTrials.gov
Summary
The study is being conducted to evaluate the safety and tolerability of HRS-2162 injection in a single dose in healthy subjects, as well as the characteristics of PK/PD
Official title: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of HRS-2162 Injection in Healthy Subjects
Key Details
Gender
All
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
64
Start Date
2025-09-25
Completion Date
2025-12
Last Updated
2025-11-17
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
HRS-2162
HRS-2162
DRUG
Placebo
Placebo
Locations (1)
Sichuan Academy of Medical Sciences &Sichuan Provincial People's Hospital
Chengdu, Sichuan, China